患有非小细胞肺癌的吸烟者的致病突变:下一代测序研究研究
1Medical Oncology Translational Research Lab, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital, Changchun, China.
Translational lung cancer research
|October 24, 2025
概括
这项研究确定了晚期非小细胞肺癌 (NSCLC) 吸烟者的特征基因突变. EGFR和KRAS是常见的驱动突变,而TP53是最常见的并发突变,指导精确的向治疗.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 吸烟是肺癌的主要原因,但吸烟患者的特征基因突变仍未得到充分研究.
- 氨酸激酶抑制剂 (TKI) 向治疗改善了晚期非小细胞肺癌 (NSCLC) 的治疗结果.
研究的目的:
- 为了研究晚期非小细胞肺癌 (NSCLC) 的吸烟患者的特定致病基因突变.
- 在这个患者队列中,比较不同样本类型 (组织,血,多叶流液) 的突变概况.
主要方法:
- 使用下一代测序 (NGS) 进行基因测序,对来自302名患有IIIB-IV期NSCLC的吸烟者的瘤组织,肺溢细胞和血进行测序.
- 分析包括常见驱动基因的突变率和同时发生的突变.
主要成果:
- 在吸烟NSCLC患者中,EGFR (34.8%) 和KRAS (15.9%) 是最常见的驱动基因突变.
- TP53 (66.7%),LRP1B (20.4%),RB1 (13.9%) 是最常见的同时发生的突变.
- 与组织和血相比,在多流样本中,EGFR和ROS1突变的频率明显高于组织和血.
结论:
- EGFR和KRAS是关键驱动突变,TP53是晚期NSCLC吸烟者的常见并发突变.
- 在不同样本类型中存在基因突变的显著变异,突出显示了样本选择的重要性.
- 下一代测序 (NGS) 分子类型对指导精确的向治疗在这个人群中至关重要.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
02:59Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
01:05Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
01:30Spontaneous and Induced Mutations
2.1K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.1K
03:00Next-generation Sequencing
97.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.7K